🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
MoonLake Immunotherapeutics (MLTX)
NASDAQ: MLTX · Real-Time Price · USD
11.07
+0.04 (0.36%)
Nov 20, 2026, 4:00 PM EST - Market closed

MLTX Statistics

Total Valuation

MLTX has a market cap or net worth of $942.13 million. The enterprise value is $545.29 million.

Market Cap942.13M
Enterprise Value 545.29M

Important Dates

The last earnings date was Wednesday, November 4, 2026, before market open.

Earnings Date Nov 4, 2026
Ex-Dividend Date n/a

Share Statistics

MLTX has 85.11 million shares outstanding. The number of shares has increased by 18.08% in one year.

Current Share Class 85.11M
Shares Outstanding 85.11M
Shares Change (YoY) +18.08%
Shares Change (QoQ) +15.51%
Owned by Insiders (%) 7.80%
Owned by Institutions (%) 58.01%
Float 54.36M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS 1,045.22
PB Ratio 2.47
P/TBV Ratio 2.47
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 9.13, with a Debt / Equity ratio of 0.27.

Current Ratio 9.13
Quick Ratio 8.53
Debt / Equity 0.27
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -28.98

Financial Efficiency

Return on equity (ROE) is -81.47% and return on invested capital (ROIC) is -40.69%.

Return on Equity (ROE) -81.47%
Return on Assets (ROA) -57.27%
Return on Invested Capital (ROIC) -40.69%
Return on Capital Employed (ROCE) -57.38%
Weighted Average Cost of Capital (WACC) 10.15%
Revenue Per Employee n/a
Profits Per Employee -$2.10M
Employee Count130
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, MLTX has paid $1.59 million in taxes.

Income Tax 1.59M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -18.24% in the last 52 weeks. The beta is 1.13, so MLTX's price volatility has been higher than the market average.

Beta (5Y) 1.13
52-Week Price Change -18.24%
50-Day Moving Average 11.61
200-Day Moving Average 16.16
Relative Strength Index (RSI) 44.26
Average Volume (20 Days) 1,428,055

Short Selling Information

The latest short interest is 5.47 million, so 6.43% of the outstanding shares have been sold short.

Short Interest 5.47M
Short Previous Month 7.83M
Short % of Shares Out 6.43%
Short % of Float 10.07%
Short Ratio (days to cover) 2.78

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -276.75M
Pretax Income -272.48M
Net Income -273.48M
EBITDA -273.36M
EBIT -276.75M
Earnings Per Share (EPS) -$3.66
Full Income Statement

Balance Sheet

The company has $498.46 million in cash and $101.62 million in debt, with a net cash position of $396.85 million or $4.66 per share.

Cash & Cash Equivalents 498.46M
Total Debt 101.62M
Net Cash 396.85M
Net Cash Per Share $4.66
Equity (Book Value) 381.63M
Book Value Per Share 4.48
Working Capital 474.91M
Full Balance Sheet

Cash Flow

Operating Cash Flow -244.04M
Capital Expenditures n/a
Depreciation & Amortization 3.40M
Net Borrowing 24.47M
Free Cash Flow -244.04M
FCF Per Share -$2.87
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

MLTX does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -18.08%
Shareholder Yield -18.08%
Earnings Yield -33.08%
FCF Yield -25.90%

Analyst Forecast

The average price target for MLTX is $30.29, which is 173.62% higher than the current price. The consensus rating is "Buy".

Price Target $30.29
Price Target Difference 173.62%
Analyst Consensus Buy
Analyst Count 16
Revenue Growth Forecast (3Y) n/a
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

Altman Z-Score n/a
Piotroski F-Score 2